IKS Health, a global leader in care enablement solutions supporting clinical, administrative, and financial efficiencies ...

NEW YORK CITY, NY / ACCESS Newswire / October 16, 2025 / Despite an ever-changing operating environment, companies that align ...

The FDA has accepted for review the sBLA for Afrezza (insulin human) inhalation powder in children and adolescents with type 1 or 2 diabetes.

New research found that gene therapy for children with a form of severe combined immunodeficiency was successful in 95% of ...